Register entry
Hefei Xinzhu Biological Technology Co Ltd.
- Registered sites
- 1
- Drug products
- 5
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackagingRepackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Hefei Xinzhu Biological Technology Co., Ltd. | HefeiChina | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, Repackaging | 3037651207 |
Catalogue
Marketed products
5Showing 5 of 5.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Insulin Aspart | POWDER | BULK INGREDIENT |
| - | Insulin Degludec | POWDER | BULK INGREDIENT |
| - | Insulin glargine | POWDER | BULK INGREDIENT |
| - | Teriparatide | LIQUID | BULK INGREDIENT |
| - | somatropin | LIQUID | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.